Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling

作者: Paul S. Hole , Joanna Zabkiewicz , Chinmay Munje , Zarabeth Newton , Lorna Pearn

DOI: 10.1182/BLOOD-2013-04-491944

关键词:

摘要: Excessive production of reactive oxygen species (ROS) is frequently observed in cancer and known to strongly influence hematopoietic cell function. Here we report that extracellular ROS elevated (mean >10-fold) >60% acute myeloid leukemia (AML) patients this increase attributable constitutive activation nicotinamide adenine dinucleotide phosphate oxidases (NOX). In contrast, overproduction mitochondrial was rarely observed. Elevated found be associated with lowered glutathione levels depletion antioxidant defense proteins. We also show for the first time generated were able promote proliferation AML lines, primary blasts, and, a lesser extent, normal CD34+ cells, response limited by oxidative stress pathway mediated though p38MAPK. Consistent this, p38MAPK responses attenuated expressing high ROS. These data NOX-derived can blasts they develop mechanisms suppress signaling would normally limit response. Together these adaptations predicted confer competitive advantage leukemic clone.

参考文章(50)
Tripathi P, Singh S, Tripathi Ak, Ahmad R, Singh Rk, Singh R, Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukaemia. Singapore Medical Journal. ,vol. 51, pp. 110- 115 ,(2010)
Dmitry V. Bulavin, Albert J. Fornace, p38 MAP kinase's emerging role as a tumor suppressor Advances in Cancer Research. ,vol. 92, pp. 95- 118 ,(2004) , 10.1016/S0065-230X(04)92005-2
Martin Sattler, Thomas Winkler, Shalini Verma, Christopher H. Byrne, Gautam Shrikhande, Ravi Salgia, James D. Griffin, Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. ,vol. 93, pp. 2928- 2935 ,(1999) , 10.1182/BLOOD.V93.9.2928
Richard Lawrence Darley, Alan Kenneth Burnett, Andrea P. Gallagher, David T. Bowen, Mutant RAS selectively promotes sensitivity of myeloid leukemia cells to apoptosis by a protein kinase C-dependent process Cancer Research. ,vol. 58, pp. 2029- 2035 ,(1998)
S. G. Rhee, H2O2, a necessary evil for cell signaling Science. ,vol. 312, pp. 1882- 1883 ,(2006) , 10.1126/SCIENCE.1130481
Shuchi Agrawal-Singh, Fabienne Isken, Konstantin Agelopoulos, Hans-Ulrich Klein, Nils H. Thoennissen, Gabriele Koehler, Antje Hascher, Nicole Bäumer, Wolfgang E. Berdel, Christian Thiede, Gerhard Ehninger, Anke Becker, Peter Schlenke, Yipeng Wang, Michael McClelland, Utz Krug, Steffen Koschmieder, Thomas Büchner, Dae-Yeul Yu, Shailendra Vikram Singh, Klaus Hansen, Hubert Serve, Martin Dugas, Carsten Müller-Tidow, Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood. ,vol. 119, pp. 2346- 2357 ,(2012) , 10.1182/BLOOD-2011-06-358705
M M Reddy, M S Fernandes, R Salgia, R L Levine, J D Griffin, M Sattler, NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases Leukemia. ,vol. 25, pp. 281- 289 ,(2011) , 10.1038/LEU.2010.263
Mark C Bagley, Terence Davis, Michal J Rokicki, Caroline S Widdowson, David Kipling, Synthesis of the highly selective p38 MAPK inhibitor UR-13756 for possible therapeutic use in Werner syndrome Future Medicinal Chemistry. ,vol. 2, pp. 193- 201 ,(2010) , 10.4155/FMC.09.163
Dunyaporn Trachootham, Jerome Alexandre, Peng Huang, Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nature Reviews Drug Discovery. ,vol. 8, pp. 579- 591 ,(2009) , 10.1038/NRD2803
Paul S. Hole, Lorna Pearn, Amanda J. Tonks, Philip E. James, Alan K. Burnett, Richard L. Darley, Alex Tonks, Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34 hematopoietic progenitor cells Blood. ,vol. 115, pp. 1238- 1246 ,(2010) , 10.1182/BLOOD-2009-06-222869